PharmD Info

A forum for Indian Pharmacy Professionals

Research funding schemes, UGC Approved Journals, Project Protocols, Clinical Study Designs, Clinical Trails Registry and Regulation, Biostatistics Forum.
Forum rules: General rules are applicable for this forum- Find Here
  • User avatar
Combinatorial chemistry is a powerful tool for drug discovery and development, enabling researchers to screen large numbers of compounds quickly and efficiently. One of the most promising applications of combinatorial chemistry is the identification of synergistic drug combinations. In this article, we will explore the potential of combinatorial drug combinations and their synergistic effects in the field of pharmaceutical research.

What is Synergy in Combinatorial Drug Combinations?

Synergy is a term used to describe the effect of two or more drugs working together to produce a greater effect than the sum of their individual effects. In combinatorial chemistry, synergy can be achieved by screening combinations of compounds to identify those that work together to produce a desired effect. Synergistic drug combinations have the potential to enhance efficacy, reduce toxicity, and decrease the risk of resistance compared to single drugs.

How are Combinatorial Drug Combinations Identified?

Combinatorial drug combinations can be identified through various screening methods, including high-throughput screening and mathematical modeling. High-throughput screening involves testing large numbers of compounds simultaneously, while mathematical modeling uses computational algorithms to predict drug interactions.

Once a potential combination is identified, further testing is required to confirm its synergistic effects. In vitro and in vivo assays can be used to evaluate the combination's efficacy, toxicity, and pharmacokinetic properties. These tests help determine whether the combination is safe and effective for use in humans.

Examples of Synergistic Drug Combinations

Several successful synergistic drug combinations have been identified through combinatorial chemistry. For example, the combination of a proteasome inhibitor and a histone deacetylase (HDAC) inhibitor has shown promising results in the treatment of multiple myeloma. Another example is the combination of a MEK inhibitor and a PI3K inhibitor, which has shown efficacy in the treatment of various cancers.

Challenges in Developing Combinatorial Drug Combinations

While the potential benefits of combinatorial drug combinations are significant, there are several challenges in their development. One of the main challenges is the identification of suitable drug combinations, as not all combinations produce synergistic effects. Additionally, the development of combination therapies requires extensive testing and regulatory approval, which can be time-consuming and costly.


Combinatorial chemistry is a powerful tool for identifying synergistic drug combinations, which have the potential to enhance efficacy, reduce toxicity, and decrease the risk of resistance compared to single drugs. While there are challenges in their development, the potential benefits make them an attractive area of research for the pharmaceutical industry. As research in this area continues, we can expect to see more successful synergistic drug combinations in the future.

Footnotes and endnotes are two popular methods for[…]

Are you a pharmacy student or professional looking[…]

As more people take prescription medication, there[…]

Clinical toxicology

Full syllabus note

PharmD Info - Highlights